Hopfner Robert Lorne sold EVMN
November 7, 2025 · Form 4 insider transaction
Hopfner Robert Lorne sold 25,790 shares of Evommune, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
25,790
Price
N/A
Total value
N/A
InsiderHopfner Robert Lorne
RoleDirector, 10% owner
CompanyEvommune, Inc. (EVMN)
SecuritySeries Seed Preferred Stock
Transaction codeC: Conversion of a derivative
Transaction dateNovember 7, 2025
Filing dateNovember 12, 2025
Shares owned after0
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Each share of Series Seed Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration on a 1-for-8.518 basis and had no expiration date.; The securities are held by a family trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.